ARCHIVES

Drug Company Cries Foul Over Clams Of Taxotere’s Superiority To Taxol

This article is from The Cancer Letter archive.

Vol. 19 No. 24 | June 11, 1993

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

In Brief: alberts elected To Second Term as NAS President

February 19, 1999

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center

May 8, 2013

FDA Approves Silicone Gel Breast Implants, Requires 10 Years Of Patient Follow-Up

November 24, 2006